The contract will provide resources for studies of selected agents for preclinical development.

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201100012C
Awardee
Awarding agency
Obligated
$499,580

Award facts

Opportunity
Contract value 5% obligated
  • $1,158,784.13 Current, with exercised options
  • $10,134,930.13 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition · 15 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Menlo Park, CA 94025, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00017 $0
Other Administrative Action P00016 -$8,362
Supplemental Agreement for work within scope 15 · Preclinical pharmacokinetic and pharmacological studies with anticancer & other therapeutic agents POP: 7/1/2011-6/30/2016 -$11,091
Funding Only Action 14 · NCI torp K - pharmacokinetic-pharmacodynamic study -$36,533
Funding Only Action 13 -$37,045
Funding Only Action 12 · Fund order #9 $152,289
Other Administrative Action 11 · Update fcoi provisions $0
Funding Only Action 10 · Exercise option 1 and 2 to order 9. $75,682
Other Administrative Action 9 · This modification revises article B.2. Costs to award task order 9. $37,841
Other Administrative Action 8 · This modification revises article B.2., C.2., F.2., G.7, and H.24. $0
Other Administrative Action 7 · This modification revises article C.2. And F.2. Reporting requirements. $0
Other Administrative Action 6 · This modification revises article C.2. Reporting requirements, and updates prism payment office. $0
Other Administrative Action 5 · This modification adds contract title and period of performance to header text box to be in compliance with most recent guidance. $0
Funding Only Action 4 · This modification adds funding to order 3 and extends the period of performance. $33,228
Other Administrative Action 3 · Other functions this modification awards task order 8, modifies the period of performance of task order 3, changes the COR in section G, and replaces the… $27,669
Other Administrative Action 2 · Other functions this modification restructures the contract to an IDIQ contract with fully funded orders. $0
Exercise an Option 1 · Other functions ; this modification exercise option 1, revises sections B, F, G, and I, and provides funding for work assignments 3, 4, 5, 6, and 7. $210,902
Original award $55,000
Show all 18

Quick answers

Who was awarded contract HHSN261201100012C?

HHSN261201100012C was awarded to Sri International by National Cancer Institute (National Institutes of Health) on July 1, 2011.

How much is contract HHSN261201100012C worth?

The government has obligated $499,580 on HHSN261201100012C. Its current value, with exercised options, is $1,158,784. Its potential value, with all options, is $10,134,930.

Was contract HHSN261201100012C competed?

The extent of competition for HHSN261201100012C was full and open competition. The government received 15 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login